Timik Group AB
Filip Schönbeck currently serves as the CEO of Timik Group AB since August 2024. Previously, Filip held the positions of CCO and Executive VP at STORZ MEDICAL AG from January 2022 to April 2024, where responsibilities included leading a Swiss medtech company specializing in shockwave devices. From September 2015 to February 2022, Filip was Chairman at Fysiopartner AS, achieving a significant turnaround for the physiotherapy and rehabilitation product distributor. Filip also served as Managing Director for Medema Physio AB for over a decade, overseeing substantial growth in both revenue and profit. Earlier career roles include Business Unit Director at Bausch & Lomb and various positions at Johnson & Johnson, Pfizer, and Pharmacia & Upjohn. Filip's educational background includes a Fast Lane SME Program at Hanken School of Economics and degrees in Business from The Berlin School of Economics and Law, Anglia Ruskin University, and law courses at Lund University.
This person is not in any teams
Timik Group AB
Timik Group is a Nordic medtech distributor that focuses on medical equipment for diagnosing, treating and management of acute and chronic diseases. We have extensive experience in finding innovative and reliable medical technology and distribute it to our customers across the Nordic region. Our focus areas are Anesthesia, Ventilation, Neonatal Care, Infusion, Drug Delivery, Pre-hospital, Pulmonary Diagnostics & Cardiology, Sleep & Homecare Ventilation, Sport Science, Rehabilitation and Test Equipment. We specialize in making the latest advances in these areas available and affordable for people whose everyday lives are impacted by these conditions. Timik Group’s headquarter is located in Sweden, with additional offices and service departments in Norway, Finland and Denmark. While our distribution is regional, we source innovative treatment technologies globally.